Impact of Reduction of Dust Mite Allergenic Load on Step Down of Inhaled Corticosteroids in Stable Asthma
NCT ID: NCT02773628
Last Updated: 2019-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
3 participants
INTERVENTIONAL
2016-05-31
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma
NCT01730027
Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma
NCT02528214
Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)
NCT00092144
Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma
NCT03782532
Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice.
NCT02811315
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
stable asthmatics receiving an Acar'up placebo system
Acar'up placebo system
treatment group
stable asthmatics receiving Acar'up system
Acar'up system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acar'up system
Acar'up placebo system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* controlled asthma for more than 3 months
* treatment with inhaled corticosteroids
* dust mite allergy proved by skin tests ou specific immunoglobulin E
Exclusion Criteria
* asthma-chronic obstructive pulmonary disease overlap syndrome
* ongoing desensitization for dust mite
* pregnancy
* previous use of Acar'up
16 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Saint Pierre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHu Saint Pierre
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AK/15-12-127/4581
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.